{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:34:58Z","timestamp":1778715298008,"version":"3.51.4"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2019,10,14]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Dengue Fever is a major threatening global health issue caused by a\nmosquito-borne pathogen. Even though some anti-viral drugs are now available to reduce the disease\nseverity. Still, there is a need of better drug compound to combat with dengue fever. The NS2B\/NS3\nprotease is a major therapeutic drug target for Insilco drug discovery.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials &amp; Methods:<\/jats:title>\n<jats:p>Previously, we have performed a pharmacophore features based virtual\nscreening studies, which has led to the identification of ZINC92615064 compound as a potent\nNS2B\/NS3 protease inhibitor and demonstrated its potential to act as anti-dengue drug-like compound\nusing computational approaches. In this present study, the identified lead compound ZINC92615064\nhas been made to undergo scaffold hopping based novel library generation, and the resulted novel\nlibrary of compounds has been virtually screened on to NS2B\/NS3 protease towards identifying novel\nproprietary scaffold of compound which is acting as a potent inhibitor for the given drug target of\nNS2B\/NS3.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result &amp; Conclusion:<\/jats:title>\n<jats:p>A total of 16,847 novel designed compounds library was generated using the\nscaffold hopping technology based on the structure of the lead compound ZINC92615064. Out of\nwhich, compound design no. 3718 has shown the best binding potential with a predicted IC50 value\nof 417.13 nM along with a permissible range of ADMET properties based on its descriptor values.\nThis NS2B\/NS3 protease in complex with compound 3718 was subjected to a rigorous molecular\ndynamic simulation study to further validate this complex thermodynamic stability, along with the\naim to reveal the underlying molecular level interactions and potential mode of action.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163815666180709155131","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T12:05:02Z","timestamp":1531137902000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lead Optimization Studies Towards Finding NS2B\/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds"],"prefix":"10.2174","volume":"16","author":[{"given":"Murugaboopathi","family":"Gurusamy","sequence":"first","affiliation":[{"name":"Department of CSE, School of Computing, Kalasalingam Academy of Research and Education, Krishnankoil, Tamilnadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jainul Fathima","family":"Abdul","sequence":"additional","affiliation":[{"name":"Research Scholar, Department of CSE, School of Computing, Kalasalingam Academy of Research and Education, Krishnankoil, Tamilnadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"S96-S102","volume":"215","author":"Low J","year":"2017","unstructured":"Low J; Ooi E; Vasudevan S.; Current Status of Dengue\nTherapeutics Research and Development. J Infect Dis 2017,215(suppl_2),S96-S102","journal-title":"J Infect Dis"},{"key":"ref=2","unstructured":"Dengue and severe dengue [Internet]. World Health Organization.\n2018. Available from [cited 27 June 2018]."},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.18203\/2320-6012.ijrms20160511","volume":"4","author":"Chaudhuri N.","year":"2016","unstructured":"Chaudhuri N.; Vithyavathi S.; Sankar K.; Clinical and laboratory profile of different dengue sub types in dengue virus infection. Int J Res Med Sci 2016,4(3),743-748","journal-title":"Int J Res Med Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/v9100291","volume":"9","author":"Chen S.","year":"2017","unstructured":"Chen S.; Wu Z.; Wang M.; Cheng A.; Innate immune evasion mediated by flaviviridae non-structural proteins. Viruses 2017,9(10),291","journal-title":"Viruses"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.342.6157.415","volume":"342","author":"Normile D.","year":"2013","unstructured":"Normile D.; Surprising new dengue virus throws a spanner in disease control efforts. Science 2013,342(6157),415-5","journal-title":"Science"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.vaccine.2015.12.073","volume":"34","author":"Vannice K.S.","year":"2016","unstructured":"Vannice K.S.; Durbin A.; Hombach J.; Status of vaccine research and development of vaccines for dengue. Vaccine 2016,34(26),2934-2938","journal-title":"Vaccine"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/09298665113209990062","volume":"21","author":"Velmurugan D.","year":"2013","unstructured":"Velmurugan D.; Mythily U.; Rao K.; Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue Virus Ns2b\/Ns3 protease. Protein Pept Lett 2013,21(8),815-827","journal-title":"Protein Pept Lett"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.csbj.2016.04.004","volume":"14","author":"Katsila T.","year":"2016","unstructured":"Katsila T.; Spyroulias G.A.; Patrinos G.P.; Matsoukas M.T.; Computational approaches to target identification and drug discovery. Comput Struct Biotechnol J 2016,14,177-184","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=9","first-page":"189","volume":"6","author":"Fathima A.J.","year":"2017","unstructured":"Fathima A.J.; Murugaboopathi G.; Selvam P.; Computational approaches in drug discovery: An overview. Int J Adv Res Sci and Eng 2017,6(7),189-195","journal-title":"Int J Adv Res Sci and Eng"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ddr.21222","volume":"75","author":"Hung C.","year":"2014","unstructured":"Hung C.; Chen C.; Computational approaches for drug discovery. Drug Dev Res 2014,75(6),412-418","journal-title":"Drug Dev Res"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.03543-14","volume":"59","author":"Wu H.","year":"2014","unstructured":"Wu H.; Bock S.; Snitko M.; Novel dengue virus NS2B\/NS3 protease inhibitors. Antimicrob Agents Chemother 2014,59(2),1100-1109","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmgm.2014.06.008","volume":"52","author":"Mukhametov A.","year":"2014","unstructured":"Mukhametov A.; Newhouse E.; Aziz N.; Saito J.; Alam M.; Allosteric pocket of the dengue virus (serotype 2) NS2B\/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition. J Mol Graph Model 2014,52,103-113","journal-title":"J Mol Graph Model"},{"key":"ref=13","year":"2015","unstructured":"Hariono Maywan, Ezatul E. Kamarulzaman, and Habibah A. Wahab. \"Computational design of dengue type-2 NS2B\/NS3 protease inhibitor: 2D\/3D QSAR of quinoline and its molecular docking.\" 3rd International Conference on Computation for Science and Technology (ICCST-3). Atlantis Press. 2015"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3923\/ijp.2016.621.632","volume":"12","author":"Ashfaq U","year":"2016","unstructured":"Ashfaq U; Tahir ul QM, Kiran S, et al Discovery of novel dengue NS2B\/NS3 protease inhibitors using pharmacophore modeling and molecular docking based virtual screening of the zinc database. Int J Pharmacol 2016,12(6),621-632","journal-title":"Int J Pharmacol"},{"key":"ref=15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006411","volume":"13","author":"Brecher M.","year":"2017","unstructured":"Brecher M.; Li Z.; Liu B.; A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog 2017,13(5)","journal-title":"PLoS Pathog"},{"key":"ref=16","author":"Fathima A.","year":"2018","unstructured":"Fathima A.; Murugaboopathi G.; Selvam P.; Pharmacophore Mapping of ligand based virtual screening, molecular docking and molecular dynamic simulation studies for finding potent NS2B\/NS3 Protease Inhibitors as potential anti-dengue drug compounds. Curr Bioinform [E-pub Ahead of Print].2018","journal-title":"Curr Bioinform"},{"key":"ref=17","unstructured":"Discovery Studio Visualization"},{"key":"ref=18","year":"2013","unstructured":"Maestro 2013","journal-title":"Maestro"},{"key":"ref=19","year":"VLifeMDS: Molecular Design Suite, VLife Sciences Technologies Pvt. Ltd., Pune, India 2010","unstructured":"VLifeMDS: Molecular Design Suite, VLife Sciences Technologies Pvt. Ltd., Pune, India 2010"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.6026\/97320630013388","volume":"13","author":"Latha M.","year":"2017","unstructured":"Latha M.; Saddala M.; Molecular docking based screening of a simulated HIF-1 protein model for potential inhibitors. Bioinformation 2017,13(11),388-393","journal-title":"Bioinformation"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","volume":"9","author":"Goodsell D.","year":"1996","unstructured":"Goodsell D.; Morris G.; Olson A.; Automated docking of flexible ligands: Applications of autodock. J Mol Recognit 1996,9(1),1-5","journal-title":"J Mol Recognit"},{"key":"ref=22","year":"Molecular Properties Prediction - Osiris Property Explorer [Internet]. Organic-chemistry.org. 2018 [cited 12 February 2018]. Available from","unstructured":"Molecular Properties Prediction - Osiris Property Explorer [Internet]. Organic-chemistry.org. 2018 [cited 12 February 2018]. Available from"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1107\/S0907444998009378","volume":"54","author":"Sussman J.","year":"1998","unstructured":"Sussman J.; Lin D.; Jiang J.; Protein Data Bank (PDB): Database of three-dimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr 1998,54(6),1078-1084","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1080\/07391102.2015.1004834","volume":"33","author":"Reddy S.","year":"2015","unstructured":"Reddy S.; Reddy K.; Kumari V.; Basha S.; Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase. J Biomol Struct Dyn 2015,33(12),2695-2709","journal-title":"J Biomol Struct Dyn"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"Morris G.","year":"1998","unstructured":"Morris G.; Goodsell D.; Halliday R.; Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998,19(14),1639-1662","journal-title":"J Comput Chem"},{"key":"ref=26","year":"Maestro-Desmond Interoperability Tools, version 3.6, Schr\u00f6dinger, New York, NY 2013","unstructured":"Maestro-Desmond Interoperability Tools, version 3.6, Schr\u00f6dinger, New York, NY 2013"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"Jorgensen W.","year":"1996","unstructured":"Jorgensen W.; Maxwell D.; Tirado-Rives J.; Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J Am Chem Soc 1996,118(45),11225-11236","journal-title":"J Am Chem Soc"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"Mark P.","year":"2001","unstructured":"Mark P.; Nilsson L.; Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 2001,105(5),9954-9960","journal-title":"J Phys Chem A"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"Lipinski C.","year":"2004","unstructured":"Lipinski C.; Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol 2004,1(43),337-341","journal-title":"Drug Discov Today Technol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"Lobanov M.","year":"2008","unstructured":"Lobanov M.; Bogatyreva N.; Galzitskaya O.; Radius of gyration as an indicator of protein structure compactness. Mol Biol 2008,42(4),623-628","journal-title":"Mol Biol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jmb.2009.05.068","volume":"391","author":"DuBay K.","year":"2009","unstructured":"DuBay K.; Geissler P.; Calculation of proteins\u2019 total side-chain torsional entropy and its influence on protein-ligand interactions. J Mol Biol 2009,391(2),484-497","journal-title":"J Mol Biol"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T06:16:41Z","timestamp":1575008201000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163648\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163815666180709155131","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}